microdosing glp 1 for maintenance GLP-1 Why GLP-1 Microdosing? A Closer

GLP-1 and the Primary Hallmarks of Aging In looking first at the primary hallmarks, evidence remains limited on how GLP-1s influence these specific hallmarks

As their use becomes increasingly widespread thanks to high-profile drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), questions about their long-term safety, efficacy and impact on body composition remain at the forefront

Niazi explains that tirzepatide is a newer dual-agonist that targets both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, which he says offers superior metabolic regulation and appetite suppression. Mounjaro is currently FDA-approved for type 2 diabetes, and Zepbound is also FDA-approved for weight loss

Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding